• About
    • About Sutro
    • Leadership
      • Leadership Team
      • Functional Leadership Team
      • Board of Directors
      • Scientific Advisory Board
      • Clinical Advisory Board
    • Collaborations
    • Corporate Presentation
  • Clinical Trials & CUA
    • Clinical Trials
      • REFRaME-O1
    • Patient Resources
    • Commitment To Patients
    • Compassionate Use Access
  • Technology
    • iADCs & Antibody-Drug Conjugates
    • XpressCF+®
    • cGMP Facility
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Pipeline
  • News
    • News Releases
    • Clinical / Scientific Presentation & Publication Highlights
    • Events
    • Events Audio Replays
  • Careers, Culture & DEIB
    • The Way We Work
    • Join Our Team
    • DEIB
      • DEIB Newsletter
    • Environmental Sustainability
    • Internships
    • Sutroites
    • Volunteer
      • Current Volunteer Newsletter
  • Contact Us

2023 American Association for Cancer Research Annual Meeting (AACR) – Poster

Events, News, Presentations

2023 American Association for Cancer Research Annual Meeting (AACR) – Poster Abstract #4849: The anti-ROR1 ADC STRO-003 demonstrates immune-modulating properties that may enhance checkpoint blockade Andrew McGeehan, Sihong Zhou, Dayson Moreira, Robert Yuan, Indrani...

Sutro Biopharma Presents Preclinical Data for its ROR1 Targeting Antibody Drug Conjugate STRO-003 at the AACR Annual Meeting 2023

Events, News, Presentations, Press Releases

Sutro Biopharma Presents Preclinical Data for its ROR1 Targeting Antibody Drug Conjugate STRO-003 at the AACR Annual Meeting 2023 ORLANDO, FL— April 18, 2023 — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering...

13th Annual World ADC London 2023 – Presentation

Events, News, Presentations

13th Annual World ADC London 2023 – Presentation Novel Precise Homosgenous ADCs Presented by: Kristin Bedard, SVP Drug Discovery...

Sutro Biopharma to Present at the Cowen 43rd Annual Health Care Conference

Events, News, Presentations, Press Releases

Sutro Biopharma to Present at the Cowen 43rd Annual Health Care Conference SOUTH SAN FRANCISCO, Calif., March 1, 2023 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody...

41st Annual JP Morgan Healthcare Conference – Presentation

Events, News, Presentations

41st Annual JP Morgan Healthcare Conference – Presentation Webcast...

Update on STRO-002 Program and Plans for Registrational Trial in Advanced Ovarian Cancer – Presentation

Events, News, Presentations

Update on STRO-002 Program and Plans for Registrational Trial in Advanced Ovarian Cancer – Presentation Webcast...
« Older Entries
Next Entries »

Sutro Biopharma

310 Utah Ave
Suite 150
South San Francisco, CA 94080
650.392.8412

Sutro Biopharma

111 Oyster Point Blvd
South San Francisco, CA 94080
Phone: 650-881-6500
Fax: 650-553-9659

Google Map

Tweets by @SutroBio

Contact Us

General Inquires: general@sutrobio.com
Business Inquires: busdev@sutrobio.com
Investor Relations Inquires: IR@sutrobio.com
Careers:
jobs@sutrobio.com

Copyright © 2023 Sutro Biopharma, Inc. South San Francisco, California, U.S.A.
Privacy Policy
  • Follow
  • Follow
  • Follow
Sign Up for Email Alerts